China’s largest vitamin and dietary supplement (VDS) firm BYHEALTH is reaping the benefits of an expanding domestic market, as it reported yet another record year of profit and revenue growth.
Infant formula maker Bubs reported a record high gross revenue coming from corporate daigou companies, which help individual sellers navigate hurdles such as procurement and deliveries.
Nestle’s recent half-year financial results report revealed slower growth in APAC compared to its other operating regions due to continuing economic difficulties and likely local struggles with the COVID-19 pandemic.
